2026 Annual Meeting | Section Showcase: Multidisciplinary Management of Post-Concussive Autonomic Dysfunction: A Case-Based Approach

Date Monday 04/20/26

Time 11:30 AM - 12:30 PM CDT Add To Calendar

Session Format This program will be presented in-person only

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Hubs

Director(s) Mitchell G. Miglis, MD, FAAN, Rachel Pearson, MD

Topic(s) Autonomic Disorders

Learning Objectives
Learners will define Postural Orthostatic Tachycardia Syndrome (POTS) and describe an evidence-based approach to diagnosis and management.
Learners recognize post-concussive orthostatic intolerance (OI).
Learners will compare and contrast post-concussive OI with POTS and review how identifying OI after concussion can help inform treatment.
Learners will review multimodal treatment approaches for patients suffering from post-concussive OI and POTS.

CME Available 0.00 credit

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic

Event Timeline
11:30 AM - 12:30 PM CDT	Speaker	Multidisciplinary Management of Post-Concussive Autonomic Dysfunction: A Case-Based Approach Mitchell G. Miglis, MD, FAAN, Rachel Pearson, MD
11:30 AM - 11:33 AM CDT	Introduction	Introduction to the Section Showcase Mitchell G. Miglis, MD, FAAN
11:33 AM - 11:45 AM CDT	Speaker	Postural Orthostatic Tachycardia Syndrome Mitchell G. Miglis, MD, FAAN
11:45 AM - 12:00 PM CDT	Speaker	Post-Concussive Orthostatic Intolerance Rachel Pearson, MD
12:00 PM - 12:15 PM CDT	Speaker	Rehabilitation Strategies for Orthostatic Intolerance following Concussion Madison B. Harris, OT
12:15 PM - 12:30 PM CDT	Q&A	Q&A Mitchell G. Miglis, MD, FAAN, Rachel Pearson, MD, Madison B. Harris, OT

Faculty Disclosures
Rachel Pearson, MD	Dr. Pearson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Pearson has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Pediatric Subspecialty Faculy. The institution of Dr. Pearson has received research support from Pediatric Subspecialty Faculty.
Mitchell G. Miglis, MD, FAAN	Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alight Health. Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint, LLC. Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2nd MD. Dr. Miglis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Miglis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Van Cott and Talamante. The institution of Dr. Miglis has received research support from Dysautonomia International. The institution of Dr. Miglis has received research support from National Institute of Health. Dr. Miglis has received publishing royalties from a publication relating to health care.
Madison B. Harris, OT	Dr. Harris has nothing to disclose.

��ɫ��

��ɫ��